Oncorena - Crunchbase Company Profile & Funding

Q: Where is Oncorena's headquarters?

Oncorena is located in Lund, Skane Lan, Sweden.

Q: Who invested in Oncorena?

Oncorena has 4 investors including Linc And HealthCap.

Q: When was the last funding round for Oncorena?

Oncorena closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Oncorena raised to date?

Oncorena has raised obfuscated.

Overview

Oncorena

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Oncorena

CB Rank

76941

Oncorena treatment for renal cancer

Founded

obfuscation

Private

Venture - Series Unknown

Lund, Skane Lan, Sweden

11-50

www.oncorena.com/

Biotechnology

Health Care

Therapeutics

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Börje Haraldsson: Chief Scientific Officer
Jenny Nyström: Founder and Owner

Details

Legal Name

Oncorena AB

Operating Status

Active

Company Type

For Profit

Founders

Jenny Nyström

About the Company

Oncorena is a pharmaceutical company that is working on a treatment for advanced kidney cancer (metastatic renal cancer). Its goal is to confirm orellanine's potent anti-tumor activity and other clinical benefits in patients with advanced kidney cancer.

Predictions & Insights

Growth Insight

See this Growth Insight

Oncorena is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

ONC175

A synthetically produced drug for treating metastatic renal cancer, focusing on Clear-Cell Carcinoma and Papillary Renal Cell Carcinoma.

Phase I/II Clinical Trial of ONC175

A clinical trial to assess the safety, tolerability, and anti-tumor efficacy of ONC175 in patients with metastatic renal cancer.

Research & Development

Oncorena is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Oncorena	2	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Oncorena	2	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Oncorena	2	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Oncorena	2	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Oncorena	2	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Oncorena	2	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Oncorena	2	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Oncorena	2	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Oncorena	2	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Oncorena	2	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Linc	—	Venture Round - Oncorena	—
Linc	—	Venture Round - Oncorena	—
Linc	—	Venture Round - Oncorena	—
Linc	—	Venture Round - Oncorena	—
Linc	—	Venture Round - Oncorena	—